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Colocalization of demethylating enzymes and NOS and functional
effects of methylarginines in rat kidney. N°-monomethylarginine (L-
NMA) and asymmetric N°, N°-dimethylarginines (ADMA) are endoge-
nous inhibitors of cellular L-arginine uptake and/or nitric oxide (NO)
synthesis that are implicated in renal parenchymal and DahI salt-sensitive
hypertension. Since the L-arginine:(L-NMA+ADMA) ratio determines
NO synthase (NOS) activity, we compared the immunohistochemical
distribution of NOS with N°, N°-dimethylarginine dimethylaminohydro-
lase (DDAH), which inactivates dimethylarginines (DMA) and L-NMA
by hydrolysis to L-citrulline. Neuronal NOS (nNOS) was expressed
predominantly in tubular epithelial cells of macula densa (MD), endothe-
hal NOS (eNOS) in vascular endothelial cells (EC), and inducible NOS
(iNOS) quite widely in tubular epithelium, including proximal tubules
(PT), thick ascending limbs of Henle (TAL), distal convoluted tubule and
intercalated cells (IC) of the collecting duct. Immunostaining for DDAH
was present in PT, TAL, MD, and IC, and was also present in the
glomerulus, Bowman's capsule, and endothelium of blood vessels. DDAH
was detected in small vesicles of TAL and PT by electron microscopic
(EM) immunocytochemistry. To study the effects of methylarginines on
tubuloglomerular feedback (TGF) response, vehicle or methylarginines(10 M) were added to artificial tubular fluid (ATF) perfused ortho-
gradely from the late PT at 40 nI min1 while assessing changes in
glomerular capillary pressure from proximal stop flow pressure (PSF).
Whereas the maximal TGF responses were unchanged by vehicle (LTGF
0 0%) or symmetric DMA (SDMA; + 1 2%, NS), they were enhanced
by L-NMA (+22 4%, P < 0.001) and asymmetric DMA (ADMA;
+28 3%, P < 0.001). Since L-arginine transport can regulate renal
epithelial NO generation, methylarginines (10 M) or vehicle were
co-perfused orthogradely with [3H]-L-arginine from the late PT and
collected at the early distal tubule to study arginine uptake from the
perfused loop of Henle. All methylarginines reduced fractional loop [3H1
absorption significantly (P < 0.001; vehicle, 84 6; ADMA, 49 6;
SDMA, 56 6; L-NMA, 41 6%). In conclusion, sites of DDAH
expression in the vasculature or nephron are all sites of expression of an
isoform of NOS. L-NMA, ADMA, and SDMA all inhibit renal tubular
L-arginine uptake, whereas L-NMA and ADMA, but not SDMA, enhance
TGF responses. Therefore, DDAH may regulate the cellular L-arginine:
methylarginine levels in specific renal cells, thereby governing cell-specific
L-arginine uptake and NO generation in renal tubular epithelium.
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Analogs of L-arginine such as NGmonomethylarginine (L-
NMA) and asymmetric NG, N°-dimethylarginine (ADMA), in
which one of the guanidino nitrogens is methylated, are compet-
itive inhibitors of NO synthase (NOS); the enantimetric form of
ADMA, symmetric dimethylarginine (SDMA) is present in bio-
logical fluids in equimolar concentrations as ADMA but does not
inhibit NOS [1—6]. Dimethylarginines (DMAs) are produced by
endothelial cells in culture [51 and blood vessels [4], and are
present in plasma and urine of rats and human subjects [1—3].
These data suggested that ADMA and perhaps L-NMA may be
endogenous inhibitors of NOS in vivo. Indeed, ADMA inhibits the
activity of endothelium-dependent relaxation of the aorta [1],
saphenous vein [3] or cerebral blood vessels [6].
Recently, the enzyme N°, NGdimethy1arginine dimethylami-
nohydrolase (DDAH), which hydrolyzes DMA and L-NMA to
L-citrulline, has been isolated in several tissues, including kidney,
pancreas, liver, brain and aorta [7, 8]. DDAH could regulate the
L-arginine-NO pathway by governing the degradation of endog-
enous inhibitors of NOS. In the normal rat kidney, both consti-
tutive and inducible NOS isoforms are expressed in specific cell
types [9—16]. Immunohistochemical techniques have located the
constitutive, type I, neuronal NOS (nNOS) isoform in renal
tubular epithelial cells of the macula densa (MD) [9—11, 15].
RT-PCR techniques have located mRNA for nNOS at several
sites in the tubular epithelium, predominantly the inner medullary
collecting ducts [16]. Using in situ hybridization techniques,
mRNA for nNOS have been shown in macula densa [10, 15, 17].
A constitutive, type III, endothelial cell NOS (eNOS) isoform has
been immunohistochemically in endothelial cells of renal vascu-
lature [15, 18], and mRNA for eNOS have been demonstrated in
renal vasculature and glomeruli by RT-PCR methods [12]. An
inducible NOS (iNOS) has been located immunohistochemically
in the intercalated cells of the collecting duct [13] and the afferent
arterioles, thick ascending limb of Henle (TAL) and distal con-
voluted tubules of normal rats [11]. In situ hybridization methods
[14] or RT-PCR applied to microdissected nephron segments [19]
have located mRNA for iNOS in the glomerulus and several
tubular sites, predominantly the collecting duct and TAL. These
isoforms of NOS have been implicated in many functions of the
normal kidney including regulation of the tubuloglomerular feed-
back (TGF) response [9], renal microcirculation [20], and salt [21]
and proton transport [13].
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The plasma concentrations of the DMA enantimers are in-
creased in patients with chronic renal failure, and may contribute
to the elevated blood pressure and pathophysiology of the uremic
syndrome [I]. Moreover, renal excretion of ADMA is increased in
Dahi salt-sensitive, compared to the salt-resistant rat fed a
high-salt diet, and correlates with the level of blood pressure (BP)
[22]. The intracellular concentration ratio of L-arginine:(L-
NMA+ADMA) could be a regulatory factor in NO generation,
and DDAH has a role in modulation of this ratio in the cell.
However, the localization of DDAH in the kidney has not been
studied. Therefore, the first aim of the present study was to
investigate cellular and subcellular localization of DDAH in the
normal rat kidney and compare this in the same study with the
localization of different NOS isoforms.
The TGF response entails vasoconstriction of the afferent
arteriole and a reduction in the glomerular capillary pressure and
single-nephron glomerular filtration rate during delivery and
reabsorption of NaC1 at the macula densa segments [231. This
response is buffered by NO generation from nNOS in the MD [9,
24]. We have shown recently that macula densa NO generation is
limited during salt restriction by L-arginine delivery and uptake
from the lumen of the loop of Henle via system y [25]. ADMA
is a well-characterized inhibitor of NOS. In studies of endothelial
cells in culture, ADMA, but not SDMA, inhibit NOS activity [1,
4], yet both enantimers inhibit L-arginine uptake by system y
[26]. Therefore, NO generation at the MD could be regulated not
only by the rates of methylation and demethylation of L-arginine
within cells, but also by luminal delivery of methylarginines, if they
could compete with luminal L-arginine for system y transport in
the macula densa. Therefore, the second aim of the present study
was to investigate the effects of ADMA, SDMA, and L-NMA on
TGF and on the cellular [3H]-L-arginine uptake from the per-
fused loop of Henle.
METHODS
Animal preparation
For the histochemical studies, 5 male Sprague-Dawley rats
weighing 180 to 200 g were fed a standard rat chow (Na content
0.3 g 100 g) and given tap water to drink. An additional two
rats were studied after receiving lipopolysaccharides (LPS; 4 mg
kg 1 i.p.) 20 and four hours before sacrifice to induce NOS in the
kidney [19]. Rats were anesthetized with pentobarbital (50 mgkg ' i.p.). After cannulation of the abdominal aorta, the kidneys
were perfused with phosphate buffered saline (PBS) followed by
perfusion with periodate-lysine-paraformaldehyde (PLP) solu-
tion. Kidney slices for immunohistochemical studies were im-
mersed in PLP overnight at 4°C. The tissue for light microscopic
immunohistochemistry were embedded in wax (Polyethylene gly-
col 400 disterate; Polysciences Inc., Warrington, PA, USA), and
that for immunogold studies was embedded in Lowicryl. The
remaining tissue was processed for the pre-embedding immuno-
peroxidase method. These methods have been described in detail
previously [11, 13, 27].
Light microscopic immunohistochemistry
The tissue was prepared as described in detail previously [11,
13, 27]. Wax sections (2 JLm) were dewaxed, incubated first with
3% H2O to eliminate endogenous peroxidase activity, and there-
after with a monoclorial antibody directed against DDAH [7, 81 at
a dilution of 1:1000 for 60 minutes after exposure to blocking
serum. The monoclonal antibody to DDAH was raised against a
34 kD protein of DDAH extracted and purified from rat kidney
[28]. Other sections were incubated with monoclonal antibodies
against nNOS, eNOS, and iNOS at a dilution of 1:100 or a
polyclonal antibody against iNOS (all from Transduction Labora-
tories, Lexington, KY, USA) at a dilution of 1:100. The sections
were rinsed with Tris buffered saline containing 0.1% Tween 20
(TBST) and a biotinylated secondary antibody against mouse
immunoglobulin (Dako, Glostrup, Denmark) for 20 minutes.
Thereafter, sections were incubated with horseradish peroxidase
(HRP)-conjugated streptavidin for 20 minutes. HRP labeling was
detected by peroxidase substrate solution, diaminobenzidine (0.8
mM; Dojindo Laboratories, Kumamoto, Japan) and counter-
stained with hematoxylin before being examined under a light
microscope.
Electron microscopic immunoperoxidase procedure
Sections (50 /Lm) of each kidney were cut on a vibratome,
washed with 50 mM NH4CI in phosphate buffered saline, and
incubated with 0.5% bovine serum albumin in TBST for 30
minutes, followed by incubation with the primary antibody against
DDAH at 1:500 dilution overnight at 4°C. For a negative control,
other sections were incubated without the antibody. After rinsing
with TBST, the sections were incubated with a biotinylated
secondary antibody directed against mouse immunoglobulin
(Dako) for two hours and, after rinsing with TBST, were incu-
bated with the HRP-conjugated streptavidin for one hour. The
sections were rinsed and fixed with 1% glutaraldehyde in PBS for
one hour, rinsed again, and HRP labeling was detected by
peroxidase substrate solution, diaminobenzidine (0.8 mM;
Dojindo Laboratories). The sections were postfixed in 2% os-
mium tetroxide in 0.1 M sodium cacodylate buffer for one hour at
4°C and embedded in epoxy resin. Sections (1 m) were cut on an
ultramicrotome and stained with toluidine blue for light micros-
copy. Ultrathin sections for electron microscopy were cut simi-
larly, stained with lead citrate, and photographed on a transmis-
sion electron microscope (Hitachi H-7000; Hitachi, Tokyo, Japan).
Post-embedding immunogold procedure
One mm3 blocks of cortical kidney tissue were embedded in
Lowiciyl. Ultrathin sections were mounted on colloidin-coatecl
nickel grids and processed for immunogold labeling. The sections
were incubated with 0.1 M NH4C1 for one hour before rinsing with
buffer solution (0.02 M Tris HC1, 0.15 M NaC1, 0.05% Tween 20,
adjusted to pH 7.2) for 15 minutes. Primary mouse monoclonal
antibody against DDAH, with 1:400 dilution, or eNOS (Transduc-
tion Laboratories), with 1:100 dilution, was applied and the
sections were incubated overnight at 4°C. After washing them with
buffer three times for 10 minutes, 30 nm gold-labeled goat
anti-mouse lgG secondary antibody (Amersham Life Science,
Buckinghamshire, UK) was applied to the sections for two hours
in a dilution of 1:50. For double staining, the sections were rinsed
with buffer and incubated with bovine serum for 15 minutes and
the same process repeated with the other primary antibody and 15
nm immunogold particles. The sections were washed again with
buffer (0.01 M PBS) and incubated with 2% glutaraldehyde/PBS
solution for 30 minutes. Finally the sections were rinsed with
distilled water, counterstained with uranyl acetate and lead citrate
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and examined with an electron microscope (Hitachi-7000 trans-
mission electron microscope).
Western blotting
The methods used have been described in detail previously [29,
30]. The right kidney was removed immediately before perfusion
and fixation, flushed with ice-cold saline, and homogenized on ice
with a Teflon glass tissue homogenizer (Iwaki, Chiba, Japan) in 1
ml buffer (pH 7.4) containing 50 mrvt Tris, 0.2 mi EDTA, 2 mM
leupeptin, 50 mM DTT, 0.2 ms phenylmethylsuifonyl fluoride.
Homogenates were centrifuged at 12,000 g for 20 minutes. The
supernatants were diluted in sodium dodecyl sulfate (SDS) sam-
pie buffer (0.5 M Tris-HC1, 10% vol/vol glycerol, 10% wt/vol SDS,
5% vol/vol -mercaptoethanol, 0.05% wt/vol bromphenol blue).
Samples containing 600 tg protein were applied to 12.5% gel for
DDAH and 7% gel for iNOS. Proteins were separated by
SDS-PAGE, and electroblotted to nitrocellulose membrane that
were incubated with 5% non-fat dry milk in TBST for one hour,
following overnight incubation with a monoclonal antibody for
DDAH at a 1:2000 dilution or with a monoclonal antibody for
iNOS (Transduction Laboratories) at a 1:200 dilution. After
rinsing in TBST, membranes were incubated for one hour with
anti-mouse lgG antibody conjugated HRP at a 1:1000 dilution.
After rinsing with TBST, blots were detected by diaminobenzidine
with 0.3% hydrogen peroxide.
Microperfusion studies of [HI -L-arginine uptake from the
lumen of the ioop of Henle
To determine the effect of ADMA, SDMA, and L-NMA on
TGF and L-arginine transport in the loop of Henle, male
Sprague-Dawley rats (N = 20, wt 225 to 300 g) were prepared for
renal micropuncture and microperfusion as described in detail
previously [25, 31]. Rats were anesthetized with the thiobarbitu-
rate, mactin (100 mg kg 1; Research Biomedicals International,
Natick, MA, USA). They received a standard chow (Ralston-
Purina Co., St. Louis, MO, USA) with a Na content of 0.3 g 100
g1. The left kidney was immobilized and placed in a holding cup.
The loop of Henle was microperfused with a glass micropipette
(OD 10 to 12 jtm) inserted into the last convolution of a
superficial proximal tubule after placement of an immobile wax
block proximal to the perfusion site.
For studies of TGF, 12 rats were prepared. An ultramicropi-
pette (1 to 2 im OD) was inserted into the proximal tubule (PT)
upstream from the wax block. This pipette was connected to a
servocontrolled pressure recorder (Instruments for Physiology
and Medicine, La Jolla, CA, USA) to measure proximal stop flow
(PSF) pressure. Changes in PSF reflect changes in glomerular
capillary pressures. To activate TGF, the perfusion micropipette
that was filled with artificial tubular fluid (ATF) was connected to
a nanoliter perfusion pump (WPI, Sarasota, FL, USA) set to
perfuse at 40 nl min1. This provides maximal activation of TGF
responses. To study the effects of luminal delivery of methylargin-
ines on maximal TGF responses, PSF was measured during zero
perfusion and while the nephron was perfused in random order
with ATF + vehicle and ATF + L-NMA. Other nephrons were
perfused to compare the response to ATF + vehicle with ATF +
ADMA or ATF + vehicle with ATF + SDMA. All drugs were
perfused at iO M concentration. Maximal responses were
achieved within 30 to 60 seconds of perfusion, were stable over 5
to 10 minutes of perfusion, and were reversible on cessation of
perfusion.
For the studies of ioop absorption of arginine, 8 rats were
prepared, a nephron was selected, the PT blocked with wax at the
midpoint, and the distal tubule (DT) identified. A perfusion
micropipette was inserted into the last proximal convolution
downstream from the wax block. Perfusion was set at 20 nI mm
using a calibrated nanoliter perfusion pump (WPI). Precisely
timed collections of fluid were made from a second micropipette
in the early distal tubule (EDT) at the surface of the kidney.
Unidirectional L-arginine transport from the lumen of this
nephron segment was studied by orthograde perfusion of the loop
of Henle with ATF containing [3H]-L-arginine (15 cpm nl';
Amersham Life Sciences, Arlington Heights, IL, USA) and
[14C]-inulin (5 cpm nl1; ICN, Costa Mesa, CA, USA) added as
a recollection marker. The recovery of 3H and '4C were measured
at the EDT collection site. In each case, the recollection of 14C
was 90 to 110% of the rate of delivery, indicating that there were
no significant leaks. To evaluate the effects of ADMA, SDMA,
and L-NMA on L-arginine transport from the lumen of the loop
of Henle, ADMA, SDMA, and L-NMA (10—s Sigma Chemical
Co., St. Louis, MO, USA) or vehicle (0.154 M NaC1 solution) were
co-perfused with the artificial tubular fluid containing the radio-
chemical markers in random order through the test nephron. The
collectate was transferred to a constant-bore capillary tube for
measurement of tubular fluid volume prior to scintillation count-
ing.
RESULTS
Light microscopy of DDAH in the kidney
Light microscopic observation of 2 m wax sections demon-
strated that there was strong immunostaining for DDAI-I in the
endothelial cells of the arcuate (Fig. Ia) and renal arteries (Fig.
ib). Strong immunostaining for eNOS also was shown in the
endothelial cells of the arcuate artery (Fig. ic).
Immunostaining for DDAH was detected in the macula densa
in some glomeruli and also in other cells in the glomerulus and
Bowman's capsule (Fig. 2a). nNOS was present in macula densa
cells and, as reported previously [11], there was also immunostain-
ing for nNOS in Bowman's capsule cells in some glomeruli (Fig.
2b). DDAH immunoreactivity was also detected in the apical
regions of the proximal convoluted tubules (PCT; Fig. 3a) and the
cytoplasm of proximal straight tubules (PST; Fig. 3b) of the renal
cortex. In the outer medulla, DDAH immunoreactivity was
present in the TAL and in the intercalated cells of the cortical
collecting duct (CCD; Fig. 4a). In the inner medulla, there was no
significant labeling of DDAH, except for some staining in inter-
calated cells and endothelium of vasa recta (Fig. 4b). Light
microscopic examination of the I j.m Epon-sections showed
immunostaining of the apical region of the PCT and intercalated
cells of the CCD (Fig. 5a). The iNOS immunoreactivity, using a
polyclonal antibody, was seen in the intercalated cells (Fig. 5b);
TAL, PST, and vascular smooth muscle (data not shown). Using
monoclonal antibodies for iNOS, there was no significant staining
except for TAL (data not shown). The negative controls showed
no staining of any structures in the kidney. The localization of
DDAH and NOS isoforms are summarized in Table 1.
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Fig. 1. Light micrograph illustrating immunostaining for DDAH in the arcuate artery (a), renal artery (b), and immunostaining for eNOS in the
arcuate artery (c). Both DDAH and eNOS are strongly expressed in the endothelial cells of the renal vasculature. Magnification X200.
Fig. 2. Light micrographs illustrating immunostaining for DDAH (a) and uNOS (b). Immunostaining for DDAH is observed in macula densa,
glomerular and Bowman's capsular cells and, for nNOS, in macula densa cells. Magnification )<200.
Fig. 3. Light micrographs illustrating immunostaining for DDAH in proximal convoluted tubules (PCT; a) and proximal straight tubules (PST; b).
Immunostaining for DDAH is detected in the apical region of PCT cells and is diffusely expressed in the cytoplasm of PST cells. Magnification x 170.
Fig. 4. Light micrographs illustrating immunostaining for DDAH in the outer medulla (a) and inner medulla (b). Jmmunostaining for DDAH is
detected in cells of the thick asccnding limb of the ioop of Henle in the outer medulla, hut there is no significant staining in the inner medulla.
Magnification X70.
Fig. 5. Light micrographs from 1 im sections of a pre-embedding EM sample illustrating immunostaining for DDAH (a) and iNOS (b).
Immunostaining for DDAH is located in the apical regions of both the proximal convoluted tubules and intercalated cells of the cortical collecting duct,
whereas iNOS is expressed only in the intercalated cells. Magnification X180.
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Table 1. Immunostaining for DDAH and NOS isoforms in normal rat
kidney
DDAH nNOS eNOS
iNOS
Monoclonal
Ab
Polyclonal
Ab
Bowman's capsule + + (1 0 0
Glomerulus + 0 + 0 0
PCT + 0 0 0 +
PST + 0 0 0 +
TAL + 0 0 + +
MD + + 0 0 0
DCT 0 0 0 0 +
CCD + 0 0 0 +
OMCD 0 0 0 0 +
IMCD 0 + 0 0 +
Vessel
Endothelium + 0 + 0 0
SMC 0 0 0 0 +
Abbreviations are: Ab, antibody; PCT, proximal convoluted tubule;
PST, proximal straight tubule; TAL, thick ascending limb of loop of
Henle; DCT, distal convoluted tubule; CCD, cortical collecting duct;
OMCD, outer medullary collecting duct; IMCD, inner medullary collect-
ing duct; SMC, smooth muscle cell; +, immunostaining present; 0,
immunostaining absent.
Electron microscopic distribution of DDAII
When examined by electron microscopy using the pre-embed-
ding method, DDAH was detected in apical vesicles of the PCT
(Fig. 6A) and in small vesicles through the cytoplasm of the TAL
(Fig. 6B). There was no staining in the brush border membrane of
the proximal tubule, mitochondria, and nuclei. Type A interca-
lated cells of the collecting duct showed some immunoreactivity,
whereas adjacent principal cells were not stained (Fig. 6C). Type
B cells also showed some immunoreactivity for DDAH (Fig. 6D).
The immunogold method reconfirmed localization both DDAH
and eNDS in glomerular endothelial cells (Fig. 7). Double
staining was attempted with two different sizes of immunogold
particles to determine whether DDAH and eNDS were colocal-
ized. This demonstrated that both were expressed in the cyto-
plasm of glomerular endothelial cells (Fig. 7c).
Protein expression for DDAH and iNOS
Western blotting was used to detect DDAH and iNOS protein
expressed in homogenates of kidneys from normal rats and rats
stimulated with LPS. The antibody for DDAH produced a single
band that corresponds to the DDAH protein with a molecular
weight of 34 kDa. The kidney of LPS-injected rats demonstrated
a band for DDAH with a similar density as seen in the normal rat,
indicating that DDAH was not induced by LPS (Fig. 8). In
contrast, Western blotting for iNOS did not detect a protein band
in kidneys from normal rats but clearly detected a band corre-
sponding to iNOS with a molecular weight of 130 kDa in the
kidney after induction by LPS (Fig. 8).
Effects of methylarginines on TGF
As shown in Figure 9, rats had a strong maximal TGF response
when tested by orthograde microperfusion of ATF into the ioop
of Henle at 40 nI min' that did not differ between groups.
Addition of vehicle to ATF did not modify the response. Likewise,
the response was not altered by SDMA (PSF before, 7.2 0.4
vs. SDMA, 7.2 0.4 mm Hg; N = 6; NS). However, L-NMA or
ADMA both increase the response significantly (PSF before,
8.3 0.7 vs. L-NMA, 10.3 1.1 mm Hg; N = 6; P < 0.01; before,
7.7 0.4 vs. ADMA, 9.8 0.5 mm Hg; N = 7; P < 0.01).
Effect of DMA and L-NMA on L-arginine transport
As shown in Figure 10, much of the [3H]-L-arginine microper-
fused with ATF + vehicle from the late PT was reabsorbed from
the loop of Henle by the EDT (84 6%). Addition of L-NMA,
ADMA or SDMA all reduced the fractional loop [3H]-L-arginine
reabsorption significantly (P < 0.01). Fractional reabsorption
averaged 41 6% with L-NMA, 49 6% with ADMA, and 56
5% with SDMA. These values did not differ significantly between
the methylarginine derivatives.
Table 2 contains a comparison of the effects of the methylargi-
nine derivatives on TGF and [3H]-L-arginine absorption from the
perfused loop of Henle. It is apparent that ADMA is as effective
as L-NMA in both test systems, yet SDMA is effective only in
preventing L-arginine uptake.
DISCUSSION
The main new findings from the present study are that sites of
localization of DDAH correspond with sites of localization of
NOS isoforms in the normal rat kidney. Unlike iNOS, DDAH is
not strongly induced by LPS. Both ADMA and L-NMA enhance
maximal TGF responses when microperfused luminally into the
macula densa, whereas SDMA is ineffective. In contrast, all three
methylarginine derivatives inhibit [3H]-L-arginine uptake from
the perfused loop of Henle to a similar degree.
Strong immunoreactivity for DDAH was observed in the endo-
thelial cells of renal vasculature, including the main renal and
arcuate arteries where eNDS was also shown clearly by light
microscopic immunohistochemistry as in previous studies [15, 18,
30]. Using the EM immunogold method, DDAH and ecNOS were
both located in glomerular endothelial cells. Immunocytochemi-
cal expression of eNDS in small renal vessels was clearly seen in
this study. Therefore, DDAH and eNDS share common cell types
of expression in the renal vascular endothelium.
Strong and uniform immunoreactive staining for nNOS was
detected in the population of macula densa cells as in previous
studies [9—11, 15, 27]. There was immunostaining in these cells
also for DDAH, but, unlike nNOS, it was variable, and some
macula densa cells were not stained with the antibody for DDAH.
There was staining of the intercalated cells of the cortical
collecting duct with the polyclonal antibody to iNOS, as in
previous studies [13]. This was also a site for immunostaining for
DDAH. There was also staining for iNOS with the polyclonal
antibody in the TAL and collecting ducts of the normal rat,
corresponding to sites of iNOS immunoreactivity [13] or mRNA
expression [14, 19] shown previously. In the present study, DDAH
was also expressed at these sites.
The sites of expression of DDAH and NOS are compared in
Table 1. It is apparent that all sites of immunoexpression for
DDAH are also sites for expression of one of the NOS isoforms
(Table 1). The only exception is that, whereas all cells of the
macula densa stain uniformly and strongly for nNOS, immuno-
staining at this site for DDAH is more variable and some cells
appear negative. It is not clear whether this represents a technical
problem of DDAH antibody interaction with macula densa
DDAH antigen or a genuine cell-to-cell variability in DDAH
expression. The concurrence in immunoreactive staining cannot
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Fig. 6. Electron micrograph illustrating DDAH immunostaining using pre-embedding method in PCT (A), TAL (B), type A intercalated cells in the
cortical collecting duct (CCD; C), and type B intercalated cells in the CCD (D) from normal rat kidney. Magnification: (A) X18,000; (B) >< 10,000; (C)
X4,500; (D) X6,000.
be ascribed to cross-reactivity of the antibody because, as shown in
Western analysis, DDAH antibodies recognize a single antigen at
a molecular weight that corresponded to that of DDAH but not to
any of the NOS isoforms.
The proximal tubule was a second site at which immunostaining
for DDAH was not matched by staining for NOS. DDAH was
strongly expressed in the apical region of PCT and in the
cytoplasm of the PST, whereas there was rather inconsistent
immunostaining for iNOS isoform of these cells under normal
conditions. However, the proximal tubule is a site of NO gener-
ation. Thus, inhibition of NOS decreases NaCI and fluid reabsorp-
tion from superficial proximal convoluted tubule of the rat [32],
or, in contrast, NO inhibits Na '1H exchanger in rabbit proximal
tubules [33] and also inhibits Na,K' -ATPase in proximal tubule
cells cultured from the mouse [34]. These data suggest that
endogenous NO inhibits Na reabsorption in proximal tubules.
LLC-PK1 cells of proximal tubule origin express a functional NOS
[35, 36], and iNOS can he induced plentifully in PCT cells in
culture [37]. Moreover, mRNA for iNOS [19] and eNOS [12, 16]
can be detected by RT-PCR techniques in microdissected proxi-
mal tubules. Therefore, although not detected consistently by
immunohistochemical methods in this study, NOS is apparently
expressed with DDAH in proximal tubular epithelium.
Western analysis of whole-kidney homogenates confirmed that
LPS induced iNOS strongly [19]. Functional expression of iNOS
following stimulation by LPS has been shown in mesangial cells
[38] and proximal tubule and inner medullary collecting duct cells
[39, 40]. In contrast, the LPS challenge did not appear to induce
DDAH expression. The difference in response to LPS between
DDAH and iNOS suggests that these two enzymes have distinct
regulatory pathways.
The normal plasma level of ADMA and SDMA are about 1 jovi
[1]. This level of ADMA alone is probably not sufficient to inhibit
NOS significantly. However, the concentrations of ADMA and
SDMA increase substantially in the plasma of patients with
uremia [1]. Moreover, these concentrations may well he much
higher within certain cells since methylarginines are substrates for
system y transport into vascular endothelial and macrophage
cells [26] and should thereby he concentrated intracellularly in
cells that possess this transport characteristic. A system y
transport process has been located in blood vessels, vascular
endothelial cells [26], macrophages [26, 41], and neuronal cells
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Fig. 7. Electron micrograph illustrating DDAH (a) and eNOS (b) immu-
nostaining and double staining (c) with the immunogold method in
normal rat glomeruli. Immunogold labeling for DDAH and eNOS is
located in the glomerular endothelium. In panel c, eNOS is labeled with 30
nm and DDAH with 15 nm immunogold. Magnification X26,000.
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Fig. 8. Western blotting studies of DDAH and iNOS expression in the
kidneys of the normal and LPS.injected rat. A strong band for DDAH is
shown at 34 kDa in normal rat kidney, but it is not apparently induced by
LPS treatment. A strong band for iNOS is seen at 130 kDa in kidneys from
LPS-treated rats but is not seen in kidneys from normal rats. Molecular
weight markers are shown.
[42] as well as the ioop of Henle of the rat kidney [25, 31.At these
sites, cellular uptake of monomethyl- and dimethylarginine should
be enhanced. SDMA, in addition to ADMA and L-NMA, are all
substrates for transport at vascular endothelial cells, where
they compete with arginine and other cationic amino acids for
cellular uptake [26]. This consistent with the present finding that
these three methylarginine derivatives were equally potent inhib-
itors of [3HJ-L-arginine uptake from the perfused loop of Henle.
We have shown previously that NO formed from NOS in the
juxtaglomerular apparatus blunts expression of the TGF re-
sponses of normal or salt-replete rats [9, 24]. Recently, we found
that microperfusion of L-arginine into the lumen of the macula
densa blunts the TGF responses of normal or salt-depleted rats
[25]. This effect depends on uptake of L-arginine via system y
since it is prevented by co-perfusion with an excess of the
competing amino acid, L-lysine. It also depends on NOS since the
response to arginine is stereospecific and is prevented by L-NMA.
Thus, in salt-depleted rats, macula densa NO generation can be
limited by L-arginine availability and cellular uptake. Where the
intracellular levels of L-arginine can be below those required for
maximum rates of NO generation from NOS, as at the macula
densa, DDAH could be especially important in regulating NO
generation. NOS activity at these sites should be a function of the
intracellular ratio of L-arginine: (L-NMA + ADMA). Therefore,
the co-localization of DDAH and NOS at several sites in the
kidney is of interest, since it implies that these two regulatory
enzymes could interact to set the level of NO generation at these
segments. However, the details of this potential interaction be-
tween L-arginine and methylarginines has not yet been explored.
It is uncertain whether ADMA within cells could inhibit L-
arginine uptake via a trans effect.
The hypothesis that the L-arginine:methylarginine ratio can
regulate NO generation in vivo has been tested recently in the
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Fig. 9. Effect of methylarginines on maximal TGF responses. Mean
SEM values for maxima! TGF responses, assessed from changes in proximal
stop flow pressure during increases in ATF perfusion from zero to 40 n1
min* Data are shown before (B) and during (D) addition to ATF of
vehicle (N = 10), L-NMA (N = 5), ADMA (N = 7), and SDMA (N = 6).N = number of nephrons. Compared to before: *p < 0.01.
Vehicle L-NMA ADMA SDMA
Fig. 10. Effect of methylarginines on loop of Henle reabsorption of
L-arginine. Mean SEM values for percentage uptake of 3H]-L-arginine
from the perfused loop of Henle. The loop was perfused orthogradely with
ATF + vehicle (N = 10), + L-NMA (N 5), + ADMA (N 10), or +
SDMA (N = 12). N — number of nephrons. Compared to before: *** <
0.00!.
hypercholesterolemic rabbit [44], which has elevated plasma levels
of ADMA and depressed levels of excretion of the NO metaho-
lites, NO2 + NO3. L-arginine administration reversed the de-
pressed L-arginine:methylargininc ratio and increases, but does
not normalize, the excretion of NO metabolites [44].
We have previously reported that NO generation in interca-
Table 2. Effects of methylarginines on potentiation of maximal TGF
responses or inhibition of labeled arginine uptake from the perfused
loop of Henle
Addition to artificial
tubular fluid perfusate
Vehicle
Change in TGF
responses %
Change in [3H]-L-arginine
uptake %
0±0 +2±3
(N=10) (N=10)
L-NMA (10 El) +22 4U —43 T
ADMA(103M)
(N=5)
+28±3k'
(N=7)
(N=5)
(N=10)
SDMA (10 M) +1 2(N=6)
—29 6U
(N=12)
Mean SEEI values from renal micropuncture and microperfusion
studies in which vehicle or drugs were added to artificial tubular fluid
perfused from the late proximal tubule.
U Compared to vehicle, P < 0.001
lated cells of the cortical collecting ducts inhibits H-ATPase [13].
DDAH could be of importance in regulating NOS activity at this
site and might thereby regulate proton secretion.
In conclusion, DDAH is colocalized with NOS in many cells in
the kidney. Whereas L-NMA and ADMA, but not SDMA,
enhance TGF responses when microperfused into the macula
densa, ADMA, SDMA, and L-NMA all impair [3H]-L-arginine
uptake from tubular fluid of the perfused ioop of Henle. These
immunocytochemical and functional data suggest that the differ-
ent methylarginines formed endogenously within the kidney might
have complex effects on NO generation. L-NMA and ADMA
appear to inhibit NOS in the JGA, whereas L-NMA, ADMA, and
SDMA inhibit epithelial uptake of L-arginine from tubular fluid
in the loop of Henle. The contrasting effects of ADMA and
SDMA on the inhibition of NOS and on arginine transport should
provide valuable investigative tools to differentiate the roles of
these two processes in NO generation.
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APPENDIX
Abbreviations used in this article are: L-NMA, N°-monomethylargin-
me; ADMA, asymmetric N°, N°-dimcthylarginine; NO, nitric oxide;
NOS, NO synthase; DDAH, N°, N°-dimethylarginine dimethylaminohy-
drolase; DMA, dimethylarginines; nNOS, neuronal NOS; MD, macula
densa; eNOS, endothelial NOS; EC, endothelial cells; iNOS, inducible
NOS; PT, proximal tubules; DT, distal tubules; EDT, early distal tubules;
TAL, thick ascending limbs of Henle; IC, intercalated cells of the
collecting duct; CCD, cortical collecting duct; EM, electron microscopic;
TGF, tubuloglomerular feedback; ATF, artificial tubular fluid; PSF,
proximal stop flow pressure; SDMA, symmetric dimethylarginine;
ADMA, asymmetric dimethylarginine.
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